Latest Compulsory license Stories
India’s government ended Bayer’s monopoly on a patented cancer drug on Monday, and has permitted a local pharmaceutical to manufacturer a less expensive generic version.
Reed Beall and Randall Kuhn of the University of Denver, USA describe in this week's PLoS Medicine their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995.
GENEVA (Reuters) - International drugs companies should seek to reduce prices for medicines sold to the poorest countries and avoid filing for patent protection there, a report prepared for the World Health Organization (WHO) said on Monday.
Australia must consider locally producing mass supplies of generic drugs to prepare for an avian flu pandemic, according to research by ANU health and legal specialists.